BioMedNewsBreaks – Jupiter Wellness Inc. (NASDAQ: JUPW) Announces Three New Executive Team Leaders

Jupiter Wellness (NASDAQ: JUPW), a wellness company focused on hair metabolism and skin therapies, has appointed three new seasoned veterans to its leadership team. The company announced that Jason Roth will serve as chief operating officer, Neil Luckianow will serve as chief commercial officer and Anthony Pedicelli will serve as director of marketing. The company noted the new leaders are part of its accelerated global expansion efforts; Jupiter is planning to launch Photocil and other products worldwide following the brand’s acquisition in 2022. Roth has worked for more than 25 years in the consumer packaged goods industry. His experience as founder and executive of global brands such as Zim’s, VeraTemp, ISI, and Mile High Labs will be “the cornerstone of Jupiter’s new proven business model,” said the company. Luckianow has extensive experience in sales/account management, product distribution, trade relations, business development, product promotion and trade marketing. He has worked as a leader several companies, including LifeScan Inc., a Johnson & Johnson company; Amira Medical, Bayer HealthCare’s Diabetes Care Division; and Facet Technologies. His expertise will significantly enhance Jupiter Wellness’s sales and marketing capabilities. Pedicelli has garnered impressive experience in overseeing marketing teams and executing successful marketing programs for multinational medical devices, luxury smart home builders and cannabis companies. Most recently, he served as director of marketing for ISI Group of Companies, where he was key in the company’s achievement of 10x revenue growth. “Jupiter Wellness is excited to welcome these talented and experienced professionals to our leadership team,” said Jupiter Wellness CEO Brian John in the press release. “This addition to the team is exactly what Jupiter was missing. We have great science and a vast product pipeline; we just needed their expertise to effectively get these products into the consumers’ hands. Once this sales and marketing platform is created, it will be invaluable to Jupiter Wellness’s ability to launch new products in the future.”

To view the full press release, visit https://ibn.fm/rBkAm

About Jupiter Wellness Inc.

Jupiter Wellness is a diversified company that supports health and wellness by researching and developing over-the-counter (“OTC”) products and intellectual property. The company’s product pipeline addresses a range of conditions, including hair loss, psoriasis and vitiligo. Revenue is generated through the sales of OTC and consumer products, contract research agreements and licensing royalties. For additional information about this company, please visit www.JupiterWellnessInc.com.

NOTE TO INVESTORS: The latest news and updates relating to JUPW are available in the company’s newsroom at https://ibn.fm/JUPW

About BioMedWire

BioMedWire (BMW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) BioMedNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. BMW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)

For more information please visit https://www.biomedwire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.biomedwire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork

Chris@BMW

Share
Published by
Chris@BMW

Recent Posts

BioMedNewsBreaks — NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Set to Report Q1 Earnings in Wake of HOPE’s Strategic Kadima Agreement

NRx Pharmaceuticals Inc. (NASDAQ: NRXP) is scheduled to report its first quarter 2025 financial results…

15 hours ago

BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Hits FDA Milestone and Expands Strategic Partnerships in Q1 Update

HeartBeam (NASDAQ: BEAT) reported Q1 2025 results highlighted by successful completion of the VALID-ECG pivotal…

21 hours ago

BioMedNewsBreaks — CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Prices $5 Million Public Offering with Institutional Investor

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company focused on brain and central nervous system cancers,…

21 hours ago

BioMedNewsBreaks – Intelligent Bio Solutions Inc. (Nasdaq: INBS) Grows Revenue, Cuts Losses in Fiscal Q3 as Cartridge Sales Drive Margins

Intelligent Bio Solutions (Nasdaq: INBS), a medical technology company delivering rapid, non-invasive testing solutions, reported…

2 days ago

BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Secures Orphan Drug Designation Transfer for TPI 287 in Brain Cancer Indications

CNS Pharmaceuticals (NASDAQ: CNSP) announced the successful transfer of Orphan Drug Designation from Cortice Biosciences…

2 days ago

BioMedNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Subsidiary HOPE Therapeutics to Acquire Kadima Neuropsychiatry Institute

NRx Pharmaceuticals (NASDAQ: NRXP) announced that its wholly owned subsidiary, HOPE Therapeutics(TM), has signed a…

2 days ago